Large-scale testing (Phase 3)Study completedNCT01480258
What this trial is testing
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,315